Well, this is hopeful news. Drugs made from bone marrow stem cells are in their final stages of human testing. From the story:
Three pivotal Phase 3 trials—the last step before seeking Food and Drug Administration approval to market a drug—are under way already for Prochrymal, and some preliminary results will be available in the first half of the year. ..
Prochymal, administered as an intravenous drip, contains a particular kind of stem cells, called mesenchymal stem cells, from adult bone marrow. All stem cells, whether from adults or embryos, have the potential to divide and form more specialized cells.Mesenchymal stem cells, [CEO C. Randall] Mills said, normally help with tissue repair and inflammation control – processes that make them potentially useful for a variety of diseases.”We don’t ask the stem cells to do anything they don’t normally do,” he said.Two of the three pivotal trials are testing Prochrymal for graft-versus-host disease (GvHD), a severe, potentially fatal, condition that occurs when the immune cells in transplanted
bone marrow attack the recipient. One trial is as an initial treatment, the other as a fallback.The third trial involves Crohn’s disease, an inflammation of the digestive tract.
Let’s keep our fingers crossed.
Dear Reader,
Can I be direct with you?
War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.
First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.
But we can’t do it without readers like you.
Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.
Your gift anchors readers in the permanent things.
Make your Fall Campaign gift now using the button below.
If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
